J & J would have been the likely acquirer. They are well funded, have global sales with no presence in the wound care space, and Swami's relationships. Just wondering if the Integra debacle changed the landscape. Acquiring PNV's product line could save Integra enormous expenses, lost time, and protect market share. Image Integra's revenues with PNV's profit margin. The lower cost of goods with BTM would allow them to expand to new locations around the world. The combined company’s EBITDA and SP would soar. The alternative might be a continuation of Integra’s spiral downwards. Integra's stock is currently trading at $42.37 US. I wonder if PNV shareholders would accept Integra's stock as payment in a buyout if there was a substantial premium to the current level.
Integra warns impact of plant closure will continue into 2024, with delays possible, page-90
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.34 |
Change
-0.030(1.27%) |
Mkt cap ! $1.616B | |||
| Open | High | Low | Value | Volume |
| $2.41 | $2.43 | $2.32 | $5.953M | 2.536M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 29039 | $2.33 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.35 | 16702 | 3 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |